Company Bellevue Life Sciences Acquisition Corp.
Equities
BLAC
US0791741087
Investment Holding Companies
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.8 USD | +0.37% | -1.01% | +2.86% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 20-02-29 |
Jin Yoo
DFI | Director of Finance/CFO | 50 | 21-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Reed
CHM | Chairman | 73 | 23-02-13 |
In-Chul Chung
BRD | Director/Board Member | 60 | 23-02-13 |
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 20-02-29 |
Jun Chul Whang
BRD | Director/Board Member | 59 | 20-07-31 |
Rad Roberts
BRD | Director/Board Member | 56 | 23-02-13 |
Jin Park
BRD | Director/Board Member | 56 | 23-02-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,041,221 | 1,940,721 ( 48.02 %) | 0 | 48.02 % |
Company contact information
Bellevue Life Sciences Acquisition Corp.
10900 NE 4th Street Suite 2300
98004, Bellevue
+
1st Jan change | Capi. | |
---|---|---|
+2.86% | 60.73M | |
+190.94% | 7.13B | |
+2.14% | 982M | |
+41.91% | 872M | |
+26.98% | 820M | |
+1.72% | 664M | |
+5.92% | 648M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- BLAC Stock
- Company Bellevue Life Sciences Acquisition Corp.